Hospital Mater Dei (BSP:MATD3) Stock Based Compensation: R$3 Mil (TTM As of Mar. 2026)


BSP:MATD3 Hospital Mater Dei SA BSP:MATD3
75 GF Score
Price R$4.77
GF Value R$2,813.62
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Hospital Mater Dei Stock Based Compensation?

Hospital Mater Dei BSP:MATD3 -2.25% 75 Stock Based Compensation is R$3 Mil as of Mar. 2026. GuruFocus rates BSP:MATD3 with a GF Score™ of 75/100 and a GF Value™ of R$2,813.62 (Possible Value Trap). The stock has 3 warning signs investors should review.

Hospital Mater Dei's Stock Based Compensation for the three months ended in Mar. 2026 was R$1 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 was R$3 Mil.

Hospital Mater Dei Stock Based Compensation Related Terms

Hospital Mater Dei Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Hospital Mater Dei's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hospital Mater Dei Stock Based Compensation Chart

Hospital Mater Dei Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only 8.56 11.70 11.70 8.32 4.25

Hospital Mater Dei Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.73 0.90 0.81 0.81 0.79
BSP:MATD3
75GF Score
Hospital Mater Dei SA BSP:MATD3
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hospital Mater Dei Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was R$3 Mil.

What does a Stock Based Compensation of R$3 Mil mean?
Hospital Mater Dei (BSP:MATD3) has a Stock Based Compensation of R$3 Mil as of Mar. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Hospital Mater Dei and its competitors.
Is Hospital Mater Dei's Stock Based Compensation too high?
Hospital Mater Dei's current Stock Based Compensation is R$3 Mil. Overall, Hospital Mater Dei has a GF Score™ of 75/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Hospital Mater Dei's Stock Based Compensation compare to HCA and THC?
Hospital Mater Dei's Stock Based Compensation of R$3 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Healthcare Providers & Services company?
A good Stock Based Compensation depends on the Healthcare Providers & Services industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Hospital Mater Dei and its competitors. Hospital Mater Dei's current Stock Based Compensation is R$3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hospital Mater Dei stock overvalued right now?
Based on GuruFocus' analysis, Hospital Mater Dei (BSP:MATD3) is currently considered Possible Value Trap. The stock's GF Value™ is R$2,813.62, compared to a current price of R$4.77 — trading 99.8% below its estimated fair value. The current Stock Based Compensation is R$3 Mil. Hospital Mater Dei's overall GF Score™ is 75/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Hospital Mater Dei (BSP:MATD3), the current Stock Based Compensation is R$3 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hospital Mater Dei (BSP:MATD3) Overvalued in 2026?

Based on GuruFocus' analysis, Hospital Mater Dei stock appears to be undervalued. The current stock price of R$4.77 is trading 99.8% below its estimated GF Value™ of R$2,813.62. GuruFocus considers Hospital Mater Dei to be Possible Value Trap.

Key valuation signals for BSP:MATD3:

  • Stock Based Compensation: R$3 Mil
  • GF Value™: R$2,813.62 vs. price of R$4.77 (99.8% below fair value)
  • GF Score™: 75/100 with 3 warning signs

No single metric tells the full story. See the BSP:MATD3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hospital Mater Dei Business Description

Address Rua Mato Grosso, No. 1, 100, Bairro Santo Agostinho, Belo Horizonte, MG, BRA, 30.190-081
Hospital Mater Dei SA is an integrated healthcare ecosystem that provides hospital and oncological services. The company provides a wide range of healthcare services, including hospitalizations, surgeries, oncology treatments, medical appointments, and diagnostic exams.
75GF Score

Get the complete analysis for BSP:MATD3

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$4.77
Price
R$2,813.62
GF Value